Researchers from Chongqing Medical University have tried to answer one of the burning questions regarding the longevity of immune response to coronavirus disease 2019 (COVID-19): How long does ...

In a recent study published in PLoS Pathogens, researchers explored probable humoral immune mechanisms related to Epstein-Barr virus (EBV) curtailment, besides neutralization, by a systematic emphasis ...

Outcomes from LDCT screening for lung cancer in an undeserved population: A quality initiative. This is an ASCO Meeting Abstract from the 2022 ASCO Annual Meeting I. This abstract does not include a ...

Prolonged Clinical and Molecular Remission in Patients With Low-Grade or Follicular Non-Hodgkin's Lymphoma Treated With Rituximab Plus CHOP Chemotherapy: 9-Year Follow-Up The unique immunoglobulin ...